MORGAN STANLEY PLC/CALL/D.R. HORTON/130/0.1/20.06.25 Share Price

Warrant

DE000MB7VZ54

Real-time Bid/Ask 17:57:42 16/07/2024 BST
3.92 EUR / 3.94 EUR +13.91% Intraday chart for MORGAN STANLEY PLC/CALL/D.R. HORTON/130/0.1/20.06.25
Current month+34.77%
1 month+27.31%
Date Price Change
16/07/24 3.88 +12.46%
15/07/24 3.45 -0.58%
12/07/24 3.47 +43.98%
11/07/24 2.41 -1.63%
10/07/24 2.45 +8.89%

Delayed Quote Börse Stuttgart

Last update July 16, 2024 at 04:24 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying DR HORTON
Issuer Morgan Stanley
WKN MB7VZ5
ISINDE000MB7VZ54
Date issued 26/06/2023
Strike 130 $
Maturity 20/06/2025 (339 Days)
Parity 10 : 1
Emission price 2.27
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.67
Lowest since issue 1.01
Delta0.8x
Omega 3.006
Premium8.11x
Gearing3.77x
Moneyness 1.226
Difference Strike -30.26 $
Difference Strike %-23.28%
Spread 0.02
Spread %0.51%
Theoretical value 3.930
Implied Volatility 38.14 %
Total Loss Probability 30.87 %
Intrinsic value 2.764
Present value 1.166
Break even 172.80 €
Theta-0.02x
Vega0.04x
Rho0.07x

Company Profile

D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (90.4%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (7.3%); - supply of financial services (2.3%).
Sector
-
More about the company

Ratings for DR Horton

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: DR Horton

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
152.2 USD
Average target price
168.4 USD
Spread / Average Target
+10.64%
Consensus